ATP/P2X7 axis modulates myeloid-derived suppressor cell functions in neuroblastoma microenvironment
暂无分享,去创建一个
F. Di Virgilio | F. Virgilio | V. Pistoia | V. Bronte | D. Marimpietri | L. Raffaghello | G. Bianchi | L. Emionite | I. Marigo | M. Vuerich | P. Pellegatti | Ilaria Marigo
[1] Bill Bynum,et al. Lancet , 2015, The Lancet.
[2] F. Virgilio. The Therapeutic Potential of Modifying Inflammasomes and NOD-Like Receptors , 2013 .
[3] V. Kumar,et al. Adenosine as an endogenous immunoregulator in cancer pathogenesis: where to go? , 2013, Purinergic Signalling.
[4] S. Ward,et al. Mitochondrial Superoxide Generation Enhances P2X7R-Mediated Loss of Cell Surface CD62L on Naive Human CD4+ T Lymphocytes , 2013, The Journal of Immunology.
[5] A. Thrasher,et al. Polyphenol E Enhances the Antitumor Immune Response in Neuroblastoma by Inactivating Myeloid Suppressor Cells , 2013, Clinical Cancer Research.
[6] F. Di Virgilio,et al. Purines, purinergic receptors, and cancer. , 2012, Cancer research.
[7] F. Di Virgilio,et al. P2 receptors and immunity , 2012, Microbes and infection.
[8] Baljit S. Khakh,et al. Neuromodulation by Extracellular ATP and P2X Receptors in the CNS , 2012, Neuron.
[9] F. Di Virgilio,et al. Expression of P2X7 receptor increases in vivo tumor growth. , 2012, Cancer research.
[10] D. Gabrilovich,et al. Coordinated regulation of myeloid cells by tumours , 2012, Nature Reviews Immunology.
[11] L. Zitvogel,et al. Inflammasomes in carcinogenesis and anticancer immune responses , 2012, Nature Immunology.
[12] F. Di Virgilio,et al. Transient P2X7 Receptor Activation Triggers Macrophage Death Independent of Toll-like Receptors 2 and 4, Caspase-1, and Pannexin-1 Proteins* , 2012, The Journal of Biological Chemistry.
[13] F. Di Virgilio,et al. Autophagy-Dependent Anticancer Immune Responses Induced by Chemotherapeutic Agents in Mice , 2011, Science.
[14] I. Biaggioni,et al. Adenosinergic Regulation of the Expansion and Immunosuppressive Activity of CD11b+Gr1+ Cells , 2011, The Journal of Immunology.
[15] L. Lazzarato,et al. Chemokine nitration prevents intratumoral infiltration of antigen-specific T cells , 2011, The Journal of experimental medicine.
[16] R. Schreiber,et al. Natural innate and adaptive immunity to cancer. , 2011, Annual review of immunology.
[17] I. Hammami,et al. Myeloid-derived suppressor cells exhibit two bioenergetic steady-states in vitro. , 2011, Journal of biotechnology.
[18] M. Smyth,et al. Extracellular adenosine triphosphate and adenosine in cancer , 2010, Oncogene.
[19] Takashi Murakami,et al. CD39/ENTPD1 expression by CD4+Foxp3+ regulatory T cells promotes hepatic metastatic tumor growth in mice. , 2010, Gastroenterology.
[20] V. Bronte,et al. Myeloid-derived suppressor cell heterogeneity and subset definition. , 2010, Current opinion in immunology.
[21] Alberto Mantovani,et al. Macrophages, innate immunity and cancer: balance, tolerance, and diversity. , 2010, Current opinion in immunology.
[22] E. Traggiai,et al. Hierarchy of immunosuppressive strength among myeloid‐derived suppressor cell subsets is determined by GM‐CSF , 2009, European journal of immunology.
[23] L. Zitvogel,et al. Chemotherapy induces ATP release from tumor cells , 2009, Cell cycle.
[24] J. Tschopp,et al. Activation of the NLRP3 inflammasome in dendritic cells induces IL-1β–dependent adaptive immunity against tumors , 2009, Nature Medicine.
[25] F. Di Virgilio,et al. Extracellular nucleotides as negative modulators of immunity. , 2009, Current opinion in pharmacology.
[26] F. Di Virgilio,et al. Expression of the P2X7 Receptor Increases the Ca2+ Content of the Endoplasmic Reticulum, Activates NFATc1, and Protects from Apoptosis* , 2009, Journal of Biological Chemistry.
[27] F. Di Virgilio,et al. P2X7: a growth-promoting receptor—implications for cancer , 2009, Purinergic Signalling Purinergic Signalling.
[28] Srinivas Nagaraj,et al. Myeloid-derived suppressor cells as regulators of the immune system , 2009, Nature Reviews Immunology.
[29] Michelle Collazo,et al. Subsets of Myeloid-Derived Suppressor Cells in Tumor-Bearing Mice1 , 2008, The Journal of Immunology.
[30] T. Whiteside. The tumor microenvironment and its role in promoting tumor growth , 2008, Oncogene.
[31] D. Carbone,et al. Host A(2B) adenosine receptors promote carcinoma growth. , 2008, Neoplasia.
[32] F. Di Virgilio,et al. Increased Level of Extracellular ATP at Tumor Sites: In Vivo Imaging with Plasma Membrane Luciferase , 2008, PloS one.
[33] I. Borrello,et al. Myeloid-derived suppressor cells promote cross-tolerance in B-cell lymphoma by expanding regulatory T cells. , 2008, Cancer research.
[34] P. De Baetselier,et al. Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell-suppressive activity. , 2008, Blood.
[35] F. Di Virgilio,et al. The P2X7 receptor: a key player in IL-1 processing and release , 2007, The Journal of Immunology.
[36] K. Stenmark,et al. Extracellular ATP is a pro-angiogenic factor for pulmonary artery vasa vasorum endothelial cells , 2007, Angiogenesis.
[37] V. Kuchroo,et al. Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression , 2007, The Journal of experimental medicine.
[38] J. Kappes,et al. Expansion of spleen myeloid suppressor cells represses NK cell cytotoxicity in tumor-bearing host. , 2007, Blood.
[39] A. Ohta,et al. A2A adenosine receptor protects tumors from antitumor T cells , 2006, Proceedings of the National Academy of Sciences.
[40] F. Di Virgilio,et al. The P2X7 receptor sustains the growth of human neuroblastoma cells through a substance P-dependent mechanism. , 2006, Cancer research.
[41] C. Divino,et al. Gr-1+CD115+ immature myeloid suppressor cells mediate the development of tumor-induced T regulatory cells and T-cell anergy in tumor-bearing host. , 2006, Cancer research.
[42] P. Sinha,et al. Interleukin-13-regulated M2 macrophages in combination with myeloid suppressor cells block immune surveillance against metastasis. , 2005, Cancer research.
[43] F. Di Virgilio,et al. A novel recombinant plasma membrane-targeted luciferase reveals a new pathway for ATP secretion. , 2005, Molecular biology of the cell.
[44] F. Di Virgilio,et al. Basal activation of the P2X7 ATP receptor elevates mitochondrial calcium and potential, increases cellular ATP levels, and promotes serum-independent growth. , 2005, Molecular biology of the cell.
[45] B. Rollins,et al. CCL2 (monocyte chemoattractant protein-1) and cancer. , 2004, Seminars in cancer biology.
[46] S. Groshen,et al. Natural Killer T Cells Infiltrate Neuroblastomas Expressing the Chemokine CCL2 , 2004, The Journal of experimental medicine.
[47] M. Slater,et al. Early prostate cancer detected using expression of non‐functional cytolytic P2X7 receptors , 2004, Histopathology.
[48] F. Di Virgilio,et al. P2X7 receptor expression in evolutive and indolent forms of chronic B lymphocytic leukemia. , 2002, Blood.
[49] D. Gabrilovich,et al. Mechanism of Immune Dysfunction in Cancer Mediated by Immature Gr-1+ Myeloid Cells1 , 2001, The Journal of Immunology.
[50] V. Mehta,et al. ATP-stimulated Release of Interleukin (IL)-1β and IL-18 Requires Priming by Lipopolysaccharide and Is Independent of Caspase-1 Cleavage* , 2001, The Journal of Biological Chemistry.
[51] H. Young,et al. Immortalized Myeloid Suppressor Cells Trigger Apoptosis in Antigen-Activated T Lymphocytes1 , 2000, The Journal of Immunology.
[52] R. Ronca,et al. Identification of a CD11b(+)/Gr-1(+)/CD31(+) myeloid progenitor capable of activating or suppressing CD8(+) T cells. , 2000, Blood.
[53] Chih‐Chung Lin,et al. P2Y2 receptor‐mediated proliferation of C6 glioma cells via activation of Ras/Raf/MEK/MAPK pathway , 2000, British journal of pharmacology.
[54] F. Di Virgilio,et al. Increased Proliferation Rate of Lymphoid Cells Transfected with the P2X7 ATP Receptor* , 1999, The Journal of Biological Chemistry.
[55] D. Ferrari,et al. P2Z purinoreceptor ligation induces activation of caspases with distinct roles in apoptotic and necrotic alterations of cell death , 1999, FEBS letters.
[56] D. Ferrari,et al. Cytolytic P2X purinoceptors , 1998, Cell Death and Differentiation.
[57] S. Gillies,et al. Targeted interleukin-2 therapy for spontaneous neuroblastoma metastases to bone marrow. , 1997, Journal of the National Cancer Institute.
[58] E. Kawashima,et al. The Cytolytic P2Z Receptor for Extracellular ATP Identified as a P2X Receptor (P2X7) , 1996, Science.
[59] F. Di Virgilio,et al. The purinergic P2Z receptor of human macrophage cells. Characterization and possible physiological role. , 1995, The Journal of clinical investigation.
[60] F. Di Virgilio,et al. Extracellular nucleotides mediate Ca2+ fluxes in J774 macrophages by two distinct mechanisms. , 1988, The Journal of biological chemistry.
[61] F. Di Virgilio,et al. Increased P2X7 receptor expression and function in thyroid papillary cancer: a new potential marker of the disease? , 2008, Endocrinology.
[62] F. Di Virgilio. The P2Z purinoceptor: an intriguing role in immunity, inflammation and cell death. , 1995, Immunology today.